Skip to main content
SpringerLink
Log in

BAY X 3702

  • Section 1: Neuroprotection in Stroke
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schwarz Th, Beckermann B, Bühner K, et al. Pharmacokinetics of the novel 5-HT1A neuro-protectant BAY X 3702 in the rat [abstract]. Soc Neurosci Abstr 1997; 23 Pt 2: 1923

    Google Scholar 

  2. De Vry J, Dietrich H, Glaser T, et al. BAY x 3702. Drugs Future 1997 Apr; 22: 341–9

    Google Scholar 

  3. Maertins T, Schwarz T, Keutz Ev, et al. Preclinical safety evaluation of BAY X 3702: a novel 5-HT1A receptor agonist with neuroprotective properties. Soc Neurosc Abstr 1997; 23 Pt 2: 1923

    Google Scholar 

  4. De Vry J, Schohe-Loop R, Heine H-G, et al. BAY X 3702, a novel aminomethylchroman derivative with potent 5-HT1A receptor agonist properties [abstract]. Soc Neurosc Abstr 1997; 23 Pt 2: 1922

    Google Scholar 

  5. Horváth E, Augstein K-H, Wittka R. Neuroprotective effect of the novel5-HT1A receptor agonist BAY X 3702 in a rat model of permanent focal cerebral ischemia and traumatic brain injury [abstract]. Soc Neurosci Abstr 1997; 23 Pt 2: 1923

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

BAY X 3702. Drugs R&D 1, 16–17 (1999). https://doi.org/10.2165/00126839-199901010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901010-00004

Keywords

Search

Navigation